J. Judice
Vorstandsvorsitzender bei DICE THER
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jeffrey Stein | M | 69 | 10 Jahre | |
| Daniel Burgess | M | 62 | 10 Jahre | |
| Richard Scheller | M | 70 |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.
DiCE Molecules, Inc.
 DiCE Molecules, Inc. Packaged SoftwareTechnology Services DiCE Molecules, Inc. is a private company that focuses on immunology and small molecule discovery. The company is based in Menlo Park, CA. The company's goal is to provide convenient oral medicines with biologic-like efficacy to patients with chronic diseases. The company was founded by J. Kevin Judice and he has been the CEO since incorporation. | 9 Jahre |
| Theodore Schroeder | M | 69 | 10 Jahre | |
| Philip Johnson | M | 59 | 1 Jahre | |
| Les Tari | M | 57 | 11 Jahre | |
| Michael Thompson | M | - | 1 Jahre | |
| Sharon Tetlow | F | 64 |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | - |
| Jim Scopa | M | 65 |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | 4 Jahre |
| Jake Simson | M | 38 |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | 3 Jahre |
| Carmen Betancourt | F | - | 10 Jahre | |
| Stephen Zachary | M | 42 |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | - |
| Shaan Gandhi | M | 38 |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | 4 Jahre |
| Allison Lewis | F | - | 9 Jahre | |
| Gordon Brooks | M | - | 1 Jahre | |
| Chris Anderson | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kevin Forrest | M | 47 | - | |
| Scott Rocklage | M | 69 | 15 Jahre | |
| John C. Doyle | M | 55 | 10 Jahre | |
| Kenneth Hillan | M | 63 | 8 Jahre | |
| Bryan Roberts | M | 57 | 15 Jahre | |
| Christopher T. Walsh | M | 80 | - | |
| Nina Kjellson | F | 49 | 1 Jahre | |
| Pehr Harbury | M | - |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | - |
| Phil Patten | M | - |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | - |
| Zeryn Sarpangal | F | 44 | 10 Jahre | |
| Paul Daruwala | M | 55 | 8 Jahre | |
| Steven Elms | M | 60 | 1 Jahre | |
| Timothy Franson | M | 72 | 9 Jahre | |
| Jon B. Bruss | M | - | - | |
| John Bedbrook | M | - |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | - |
| Robert Perez | M | 59 | 3 Jahre | |
| Camille Samuels | F | 52 | 11 Jahre | |
| Patrick Heron | M | 53 | 1 Jahre | |
| Allan S. Wagman | M | - | 7 Jahre | |
| Sunny Lee Ryan | F | 54 | 3 Jahre | |
| Daniel Bensen | M | 49 | 4 Jahre | |
| Robert More | M | 56 | - | |
| Peter G. Schultz | M | 67 | - | |
| Brady Johnson | M | - | 7 Jahre | |
| Daniel G. Marquess | M | 55 | 17 Jahre | |
| Daniel Geffken | M | 67 | 4 Jahre | |
| Christine Murray | F | 63 | 4 Jahre | |
| Marc Wilson | M | 45 | 4 Jahre | |
| Pattie Chiang | F | - | 7 Jahre | |
| Christine Welch | F | - | - | |
| Becki Filice | F | 63 | 3 Jahre | |
| Floyd E. Romesberg | M | 58 | 9 Jahre | |
| Paul Stone | M | 60 | 2 Jahre | |
| Shaw H. Warren | M | - | - | |
| Nathaniel David | M | 56 | 2 Jahre | |
| Kenneth Bartizal | M | 72 | - | |
| Dirk Thye | M | 54 | 2 Jahre | |
| John Jacobsen | M | 56 | 17 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 54 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
